UDCA Use in Primary Biliary Cholangitis Associated With Reduced Cancer Risk: JAMA
USA: A large retrospective, propensity score–matched cohort study found that ursodeoxycholic acid (UDCA) use in patients with primary biliary cholangitis (PBC) was associated with a significantly lower incidence of breast…